Evidence map›Paper›PMID 31766382›Full record

ArticleNutrients2019

An In Vitro Study on the Combination Effect of Metformin and N-Acetyl Cysteine against Hyperglycaemia-Induced Cardiac Damage.

Rabia Johnson, Nonhlakanipho F Sangweni, Sihle E Mabhida, Phiwayinkosi V Dludla, Lawrence Mabasa, Sylvia Riedel, Charna Chapman, Rebamang A Mosa, Abidemi P Kappo, Johan Louw and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Hypoglycemic effect ofFood science & nutrition · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Rabia JohnsonBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa.ORCID 0000-0002-6328-0789
Nonhlakanipho F SangweniBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa.
Sihle E MabhidaBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa.
Phiwayinkosi V DludlaBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa.
Lawrence MabasaBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa.
Sylvia RiedelBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa.
Charna ChapmanBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa.
Rebamang A MosaDepartment of Biochemistry and Microbiology, University of Zululand, Kwadlangezwa, Durban 3800, South Africa.
Abidemi P KappoDepartment of Biochemistry, Genetics and Microbiology (BGM), Division of Biochemistry, University of Pretoria, Hatfield 0028, South Africa.
Johan LouwBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa.
Christo J F MullerBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa.ORCID 0000-0001-6821-2120
South African Medical Research Council · ZAUniversity of Pretoria · ZAUniversity of Zululand · ZA

Funding

Rabia Johnson 10726
6 · The paper itself

Abstract

Chronic hyperglycaemia is a major risk factor for diabetes-induced cardiovascular dysfunction. In a hyperglycaemic state, excess production of reactive oxygen species (ROS), coupled with decreased levels of glutathione, contribute to increased lipid peroxidation and subsequent myocardial apoptosis. N-acetylcysteine (NAC) is a thiol-containing antioxidant known to protect against hyperglycaemic-induced oxidative stress by promoting the production of glutathione. While the role of NAC against oxidative stress-related cardiac dysfunction has been documented, to date data is lacking on its beneficial effect when used with glucose lowering therapies, such as metformin (MET). Thus, the aim of the study was to better understand the cardioprotective effect of NAC plus MET against hyperglycaemia-induced cardiac damage in an H9c2 cardiomyoblast model. H9c2 cardiomyoblasts were exposed to chronic high glucose concentrations for 24 h. Thereafter, cells were treated with MET, NAC or a combination of MET and NAC for an additional 24 h. The combination treatment mitigated high glucose-induced oxidative stress by improving metabolic activity i.e. ATP activity, glucose uptake (GU) and reducing lipid accumulation. The combination treatment was as effective as MET in diminishing oxidative stress, lipid peroxidation and apoptosis. We observed that the combination treatment prevented hyperglycaemic-induced cardiac damage by increasing GLUT4 expression and mitigating lipid accumulation via phosphorylation of both AMPK and AKT, while decreasing nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), as well as protein kinase C (PKC), a known activator of insulin receptor substrate-1 (IRS-1), via phosphorylation at Ser307. On this basis, the current results support the notion that the combination of NAC and MET can shield the diabetic heart against impaired glucose utilization and therefore its long-term protective effect warrants further investigation.

Indexed as

AcetylcysteineAnimalsApoptosisCardiotonic AgentsCell LineGlucoseHyperglycemiaLipid PeroxidationMetforminModels, BiologicalMyocytes, CardiacOxidative StressRatsAcetylcysteineCardiotonic AgentsGlucoseMetforminapoptosiscardiovasculardiabetesmetforminN-acetyl cysteineoxidative stress

Identifiers

PMID31766382
PMCPMC6950330
OpenAlexW2990374049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.